Salarius Pharmaceuticals, Inc.
SLRX
$5.77
$0.458.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -55.80% | -26.13% | -25.87% | 0.34% | -25.16% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -75.15% | -33.48% | -38.45% | 123.39% | -47.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 78.16% | 29.15% | -- | -- | -- |
| Total Current Assets | -41.02% | -22.84% | -21.84% | 8.79% | -27.25% |
|
|
|||||
| Total Current Assets | -41.02% | -22.84% | -21.84% | 8.79% | -27.25% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.21% | -3.11% | -3.01% | -8.52% | -25.28% |
| Total Assets | -40.46% | -22.61% | -21.67% | 8.59% | -27.23% |
|
|
|||||
| Total Accounts Payable | 0.76% | 56.96% | 465.14% | -74.22% | -9.93% |
| Total Accrued Expenses | 6.62% | 97.11% | -19.89% | -17.84% | 32.75% |
| Short-term Debt | -- | -49.44% | -32.51% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -2.41% | 50.70% | 61.71% | -20.70% | -4.51% |
|
|
|||||
| Total Current Liabilities | -2.41% | 50.70% | 61.71% | -20.70% | -4.51% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -49.44% | -32.51% | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -2.41% | 50.70% | 61.71% | -20.70% | -4.51% |
|
|
|||||
| Common Stock & APIC | 0.08% | 0.31% | 0.06% | 1.86% | 0.18% |
| Retained Earnings | -1.15% | -2.09% | -1.82% | -1.22% | -1.82% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -1,440.39% | -95.91% | -48.31% | 23.12% | -34.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1,440.39% | -95.91% | -48.31% | 23.12% | -34.91% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1,440.39% | -95.91% | -48.31% | 23.12% | -34.91% |
|
|
|||||